A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers

NCT04605159 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
11194
Enrollment
INDUSTRY
Sponsor class

Stopped Following a recommendation from the Independent Data Monitoring Committee of NCT04605159 (RSV MAT 009), GSK made the decision to stop enrolment and vaccination in the study.

Conditions

Interventions

Sponsor

GlaxoSmithKline